A phase 2 study on the treatment of hyperkalemia in patients with chronic kidney disease suggests that the selective potassium trap, ZS-9, is safe and efficient

Title
A phase 2 study on the treatment of hyperkalemia in patients with chronic kidney disease suggests that the selective potassium trap, ZS-9, is safe and efficient
Authors
Keywords
chronic kidney disease, hyperkalemia, potassium, potassium trap, zirconium silicate, ZS-9
Journal
KIDNEY INTERNATIONAL
Volume 88, Issue 2, Pages 404-411
Publisher
Elsevier BV
Online
2015-02-05
DOI
10.1038/ki.2014.382

Ask authors/readers for more resources

Reprint

Contact the author

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started